Intra-Cellular Therapies Inc. (ITCI) Social Stream
INTRA-CELLULAR THERAPIES INC (ITCI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INTRA-CELLULAR THERAPIES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 7 | $70 | $45 | $53 | $54.36 | -2.5% |
| 2021-12-06 | 7 | $70 | $45 | $53.428 | $54.36 | -1.71% |
| 2021-12-20 | 7 | $85 | $46 | $56.666 | $54.36 | 4.24% |
| 2021-12-21 | 7 | $85 | $46 | $59.285 | $54.36 | 9.06% |
| 2022-01-06 | 7 | $85 | $46 | $59.428 | $54.36 | 9.32% |
| 2022-01-23 | 7 | $85 | $46 | $60 | $54.36 | 10.38% |
| 2022-01-28 | 7 | $85 | $46 | $60.142 | $54.36 | 10.64% |
| 2022-03-02 | 7 | $90 | $49 | $64.285 | $54.36 | 18.26% |
| 2022-03-08 | 7 | $90 | $55 | $65.142 | $54.36 | 19.83% |
| 2022-04-13 | 7 | $90 | $55 | $65.857 | $54.36 | 21.15% |
| 2022-04-21 | 8 | $90 | $55 | $66.571 | $54.36 | 22.46% |
| 2022-05-11 | 9 | $90 | $55 | $66.75 | $54.36 | 22.79% |
| 2022-05-16 | 9 | $90 | $55 | $66.555 | $54.36 | 22.43% |
| 2022-06-14 | 10 | $90 | $55 | $67.4 | $54.36 | 23.99% |
| 2022-08-09 | 11 | $90 | $55 | $67.545 | $54.36 | 24.25% |
| 2022-08-15 | 11 | $90 | $57 | $69.727 | $54.36 | 28.27% |
| 2022-10-13 | 11 | $90 | $49 | $68.363 | $54.36 | 25.76% |
| 2022-11-03 | 11 | $90 | $49 | $67.636 | $54.36 | 24.42% |
| 2022-11-04 | 11 | $90 | $49 | $67.818 | $54.36 | 24.76% |
| 2023-02-08 | 11 | $93 | $49 | $70.083 | $54.36 | 28.92% |
| 2023-02-13 | 11 | $93 | $49 | $70.5 | $54.36 | 29.69% |
| 2023-03-01 | 11 | $93 | $49 | $70.916 | $54.36 | 30.46% |
| 2023-03-02 | 11 | $93 | $49 | $70.75 | $54.36 | 30.15% |
| 2023-03-28 | 11 | $93 | $49 | $70.666 | $54.36 | 30% |
| 2023-03-29 | 12 | $93 | $49 | $70.666 | $54.36 | 30% |
| 2023-04-05 | 12 | $98 | $49 | $71.666 | $54.36 | 31.84% |
| 2023-04-17 | 12 | $98 | $49 | $72 | $54.36 | 32.45% |
| 2023-05-04 | 13 | $98 | $49 | $72.615 | $54.36 | 33.58% |
| 2023-05-08 | 13 | $98 | $49 | $74.153 | $54.36 | 36.41% |
| 2023-06-06 | 13 | $98 | $49 | $74.461 | $54.36 | 36.98% |
| 2023-06-30 | 11 | $98 | $49 | $75.916 | $54.36 | 39.65% |
| 2023-08-03 | 11 | $98 | $49 | $76.5 | $54.36 | 40.73% |
| 2023-08-04 | 10 | $98 | $59 | $79.909 | $54.36 | 47% |
The Trend in the Analyst Price Target
ITCI's average price target has moved up $11.33 over the prior 16 months.
Over the past 42 weeks, ITCI's average upside potential has been 31.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-26 | 11 | 90 | 49 | 67.636 | 45.93 | 47.26% |
| 2023-03-09 | 11 | 93 | 49 | 70.666 | 44.24 | 59.73% |
| 2023-04-17 | 12 | 98 | 49 | 72.000 | 63.18 | 13.96% |
| 2023-06-06 | 13 | 98 | 49 | 75.545 | 65.41 | 15.49% |
| 2023-06-30 | 11 | 98 | 49 | 75.916 | 63.32 | 19.89% |
ITCI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 7 | 2 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
ITCI's average broker recommendation rating worsened by 0.19 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ITCI as an investment opportunity.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INTRA-CELLULAR THERAPIES INC's upside potential (average analyst target price relative to current price) is higher than 935.79% of them.
- ITCI has a higher average analyst price target than 3667.5% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INTRA-CELLULAR THERAPIES INC's number of analysts covering the stock is greater than 3303.89% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INTRA-CELLULAR THERAPIES INC's variance in analysts' estimates is lower than -3109.88% of them.
In the Pharmaceutical Products industry, PRTA, IRWD, and AGIO are the three stocks most similar to INTRA-CELLULAR THERAPIES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ITCI a Buy, Hold or Sell? See the POWR Ratings now!